Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients

作者: Myles Wolf , Joseph Betancourt , Yuchiao Chang , Anand Shah , Ming Teng

DOI: 10.1681/ASN.2007091002

关键词:

摘要: Contrary to most examples of disparities in health outcomes, black patients have improved survival compared with white after initiating hemodialysis. Understanding potential explanations for this observation may important clinical implications minorities general. This study tested the hypothesis that greater use activated vitamin D therapy accounts advantage observed and Hispanic on In a prospective cohort non-Hispanic (n = 5110), 979), 3214) incident hemodialysis patients, higher parathyroid hormone levels at baseline were primary determinant prescribing therapy. Median was highest among who likely receive dosage. One-year mortality lower (16 16 versus 23%; P < 0.01), but there significant interaction between race ethnicity, therapy, survival. multivariable analyses treated D, had 16% difference lost when adjusted contrast, untreated 35% an association persisted several sensitivity analyses. conclusion, be one explanation racial differences patients. Further studies should determine whether treatment based biologic contribute other conditions.

参考文章(54)
Stuart M. Sprague, Francisco Llach, Michael Amdahl, Carol Taccetta, Daniel Batlle, Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney International. ,vol. 63, pp. 1483- 1490 ,(2003) , 10.1046/J.1523-1755.2003.00878.X
Kevin A. Schulman, Jesse A. Berlin, William Harless, Jon F. Kerner, Shyrl Sistrunk, Bernard J. Gersh, Ross Dubé, Christopher K. Taleghani, Jennifer E. Burke, Sankey Williams, John M. Eisenberg, William Ayers, José J. Escarce, The Effect of Race and Sex on Physicians' Recommendations for Cardiac Catheterization The New England Journal of Medicine. ,vol. 340, pp. 618- 626 ,(1999) , 10.1056/NEJM199902253400806
Elizabeth R. DeLong, David B. Pryor, Robert M. Califf, Daniel B. Mark, Eric D. Peterson, Linda K. Shaw, Racial Variation in the Use of Coronary-Revascularization Procedures — Are the Differences Real? Do They Matter? The New England Journal of Medicine. ,vol. 336, pp. 480- 486 ,(1997) , 10.1056/NEJM199702133360706
F. Tentori, , W.C. Hunt, C.A. Stidley, M.R. Rohrscheib, E.J. Bedrick, K.B. Meyer, H.K. Johnson, P.G. Zager, Mortality risk among hemodialysis patients receiving different vitamin D analogs Kidney International. ,vol. 70, pp. 1858- 1865 ,(2006) , 10.1038/SJ.KI.5001868
Chi-Yuan Hsu, Feng Lin, Eric Vittinghoff, Michael G Shlipak, Racial Differences in the Progression from Chronic Renal Insufficiency to End-Stage Renal Disease in the United States Journal of the American Society of Nephrology. ,vol. 14, pp. 2902- 2907 ,(2003) , 10.1097/01.ASN.0000091586.46532.B4
C. C. Cowie, F. K. Port, K. F. Rust, M. I. Harris, Differences in Survival Between Black and White Patients With Diabetic End-Stage Renal Disease Diabetes Care. ,vol. 17, pp. 681- 687 ,(1994) , 10.2337/DIACARE.17.7.681
Jay L. Xue, Paul W. Eggers, Lawrence Y. Agodoa, Robert N. Foley, Allan J. Collins, Longitudinal Study of Racial and Ethnic Differences in Developing End-Stage Renal Disease among Aged Medicare Beneficiaries Journal of The American Society of Nephrology. ,vol. 18, pp. 1299- 1306 ,(2007) , 10.1681/ASN.2006050524
K. Kalantar-Zadeh, N. Kuwae, D.L. Regidor, C.P. Kovesdy, R.D. Kilpatrick, C.S. Shinaberger, C.J. McAllister, M.J. Budoff, I.B. Salusky, J.D. Kopple, Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients Kidney International. ,vol. 70, pp. 771- 780 ,(2006) , 10.1038/SJ.KI.5001514